{"id":17292,"date":"2026-08-27T08:41:20","date_gmt":"2026-08-27T08:41:20","guid":{"rendered":"https:\/\/www.btse.com\/blog\/?p=17292"},"modified":"2026-08-27T08:41:20","modified_gmt":"2026-08-27T08:41:20","slug":"trade-mrna-perpetual-futures","status":"publish","type":"post","link":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/","title":{"rendered":"How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures"},"content":{"rendered":"<p><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">Few stocks demonstrate why leveraged perpetual futures exist quite like Moderna just did. On August 19, 2026, MRNA shares rocketed 177% in a single session \u2014 the largest one-day gain in the company&#8217;s history \u2014 before giving back nearly 20% the very next day (<\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.biospace.com\/drug-development\/moderna-stock-nearly-doubles-as-merck-partnered-mrna-cancer-vaccine-meets-phase-3-goal\"><span style=\"font-weight: 400;\">BioSpace<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">). That&#8217;s not a typo, and it&#8217;s exactly the kind of move that makes biotech one of the most compelling sectors for traders looking to <\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.btse.com\/blog\/stock-and-gold-perpetual-futures-are-now-available-for-trading-on-btse\/\"><span style=\"font-weight: 400;\">trade MRNA futures<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\"> rather than the underlying stock alone.<\/span><\/span><\/p>\n<h2><span style=\"font-weight: 400; font-family: inter; color: #000000;\">MRNA at a Glance: Why Trade Moderna Perpetual Futures<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Ticker:<\/b><span style=\"font-weight: 400;\"> MRNA (Nasdaq)<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Business:<\/b><span style=\"font-weight: 400;\"> mRNA-based vaccines and therapeutics \u2014 COVID-19 (Spikevax), RSV (mResvia), and a fast-advancing oncology pipeline<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Catalyst:<\/b><span style=\"font-weight: 400;\"> Positive Phase 3 results for intismeran autogene (mRNA-4157\/V940), a personalized cancer vaccine developed with Merck \u2014 the first-ever positive late-stage trial for an mRNA cancer therapy<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Price action:<\/b><span style=\"font-weight: 400;\"> Shares moved from $62.96 to a 52-week high of $176.66 intraday, closed at $174.38, then fell to around $140 the next session \u2014 still more than 150% above pre-catalyst levels<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Volume:<\/b><span style=\"font-weight: 400;\"> 185.1 million shares traded on the rally day, roughly 1,819% above the three-month average of 9.6 million (<\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.fxleaders.com\/news\/2026\/08\/21\/moderna-stock-mrna-cancer-vaccine-breakthrough\/\"><span style=\"font-weight: 400;\">FX Leaders<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">)<\/span><\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400; font-family: inter; color: #000000;\"><br \/>\nWhat Just Happened: Moderna&#8217;s Record Rally, Explained<\/span><\/h2>\n<p><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">The move wasn&#8217;t hype \u2014 it was a genuine clinical milestone. Moderna and Merck&#8217;s Phase 3 INTerpath-001 trial tested intismeran autogene (an individualized neoantigen therapy built from a patient&#8217;s own tumor) combined with Merck&#8217;s Keytruda in 1,137 patients with resected melanoma. The combination significantly improved recurrence-free survival and distant metastasis-free survival compared to Keytruda alone \u2014 the first positive Phase 3 result ever recorded for an mRNA-based cancer treatment (<\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.merck.com\/news\/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient\/\"><span style=\"font-weight: 400;\">Merck<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">).<\/span><\/span><\/p>\n<p><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">William Blair analysts upgraded the stock to Outperform from Market Perform on the news, writing that Moderna now has &#8220;a clear line of sight to revenue diversification&#8221; beyond its shrinking COVID-19 franchise (<\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.biospace.com\/drug-development\/moderna-stock-nearly-doubles-as-merck-partnered-mrna-cancer-vaccine-meets-phase-3-goal\"><span style=\"font-weight: 400;\">BioSpace<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">). The trial results built on five-year follow-up data from an earlier Phase 2b study showing the combination cut the risk of recurrence or death by 49% versus Keytruda alone (<\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.ajmc.com\/view\/moderna-merck-mrna-cancer-vaccine-succeeds-in-late-stage-trial\"><span style=\"font-weight: 400;\">AJMC<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">). For a stock that had fallen more than 90% from its pandemic-era peak, that&#8217;s the kind of narrative shift that can redraw a multi-year chart in 48 hours.<\/span><\/span><\/p>\n<h2><span style=\"font-weight: 400; font-family: inter; color: #000000;\">Why Biotech Stocks Like MRNA Are Built for Perpetual Futures Trading<\/span><\/h2>\n<p><span style=\"font-weight: 400; font-family: inter; color: #000000; font-size: 14pt;\">Clinical trial readouts are binary, scheduled, and often announced outside standard market hours \u2014 a combination that makes biotech uniquely suited to 24\/7 trading instruments. A Phase 3 result can drop via press release at 4 a.m. Eastern, and by the time Nasdaq opens, the move has often already happened. Perpetual futures let traders react the moment news breaks instead of waiting for the bell.<\/span><\/p>\n<p><span style=\"font-weight: 400; font-family: inter; color: #000000; font-size: 14pt;\">Biotech binary events also cut both ways harder than almost any other sector. A single trial can double a stock overnight \u2014 or, if the data disappoints, erase most of a company&#8217;s value in an afternoon. That two-sided, headline-driven volatility is exactly what separates a &#8220;buy and hold&#8221; stock from a trading vehicle.<\/span><\/p>\n<h2><span style=\"font-weight: 400; font-family: inter; color: #000000;\">How to Trade MRNA Perpetuals on BTSE<\/span><\/h2>\n<p><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">Trading a stock that can move 177% in a session and then give back 20% the next day requires infrastructure built for speed and flexibility \u2014 not a brokerage account that closes for the night. <\/span><b>MRNA perpetual futures on BTSE are designed for exactly that:<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Trade 24\/7<\/b><span style=\"font-weight: 400;\"> \u2014 clinical trial data, FDA decisions, and partner announcements don&#8217;t wait for market hours<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Go long or short<\/b><span style=\"font-weight: 400;\"> \u2014 trade a positive catalyst or fade an overextended rally<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Leverage available<\/b><span style=\"font-weight: 400;\"> \u2014 control a larger position with less upfront capital, sized to the instrument&#8217;s real volatility<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>No expiry<\/b><span style=\"font-weight: 400;\"> \u2014 hold as long as you maintain margin<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Stablecoin settlement<\/b><span style=\"font-weight: 400;\"> \u2014 manage MRNA alongside your other stock and crypto perps from a single USDT wallet<\/span><\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 14pt; font-family: inter; color: #000000;\"><span style=\"font-weight: 400;\"><br \/>\nNew to perps? Start with <\/span><\/span><span style=\"font-size: 14pt; font-family: inter;\"><a href=\"https:\/\/www.btse.com\/blog\/blog-what-are-perpetual-futures\/\"><span style=\"font-weight: 400;\">what perpetual futures are and how they work<\/span><\/a><\/span><span style=\"font-size: 14pt; font-family: inter; color: #000000;\"><span style=\"font-weight: 400;\">, then read the <\/span><\/span><span style=\"font-size: 14pt; font-family: inter;\"><a href=\"https:\/\/www.btse.com\/blog\/stock-perps-on-btse-the-10-questions-traders-ask-most\/\"><span style=\"font-weight: 400;\">10 most common stock perp questions, answered<\/span><\/a><\/span><span style=\"font-size: 14pt; font-family: inter; color: #000000;\"><span style=\"font-weight: 400;\"> before placing your first trade.<\/span><\/span><\/p>\n<h2><span style=\"font-weight: 400; font-family: inter; color: #000000;\">Understanding the MRNA Perpetual Contract: Leverage, Funding, and Risk<\/span><\/h2>\n<p><span style=\"font-weight: 400; font-family: inter; color: #000000; font-size: 14pt;\">A perpetual contract on a stock this volatile behaves differently than one on a slower-moving blue chip, and that difference matters for how you size a position. Moderna&#8217;s post-catalyst pullback \u2014 nearly 20% in a single session, on top of the prior day&#8217;s 177% spike \u2014 shows how quickly an MRNA perpetual contract can swing in either direction even after the initial headline has already been priced in.<\/span><\/p>\n<p><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">Before opening a leveraged MRNA position, it&#8217;s worth reviewing our <\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.btse.com\/blog\/managing-risk-in-futures-trading-the-importance-of-margin-and-leverage\/\"><span style=\"font-weight: 400;\">risk management guide for margin and leverage<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\">, and if you&#8217;re newer to leveraged trading generally, our <\/span><\/span><span style=\"font-family: inter; font-size: 14pt;\"><a href=\"https:\/\/www.btse.com\/blog\/crypto-leverage-for-beginners\/\"><span style=\"font-weight: 400;\">beginner&#8217;s guide to leverage<\/span><\/a><\/span><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><span style=\"font-weight: 400;\"> covers the fundamentals in plain English.<\/span><\/span><\/p>\n<h2><span style=\"font-weight: 400; font-family: inter; color: #000000;\">Quick Tips for Trading MRNA Stock Futures<\/span><\/h2>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Track the regulatory calendar, not just the chart.<\/b><span style=\"font-weight: 400;\"> Moderna and Merck still need to file for approval on intismeran autogene \u2014 every regulatory milestone from here is a potential catalyst.<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Size for binary-event volatility.<\/b><span style=\"font-weight: 400;\"> A stock that moved 177% and then -20% in back-to-back sessions needs materially smaller position sizing than a typical large-cap.<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Watch the base business alongside the pipeline.<\/b><span style=\"font-weight: 400;\"> Spikevax and mResvia revenue trends still matter \u2014 they&#8217;re the financial floor beneath the oncology growth story.<\/span><\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-family: inter; color: #000000; font-size: 14pt;\"><b>Use a stop-loss every time.<\/b><span style=\"font-weight: 400;\"> Post-catalyst pullbacks like MRNA&#8217;s 19.83% one-day drop can happen even when the underlying news is genuinely positive, purely on valuation and profit-taking.<\/span><\/span><\/li>\n<\/ol>\n<h2><span style=\"font-weight: 400; font-family: inter; color: #000000;\"><br \/>\nThe Bottom Line<\/span><\/h2>\n<p><span style=\"font-weight: 400; font-family: inter; color: #000000; font-size: 14pt;\">Moderna just delivered a textbook example of why biotech and perpetual futures are such a natural fit: a genuine scientific breakthrough, a record-setting price move, and enough two-way volatility in 48 hours to reward traders on both sides of the trade. Whether you think the cancer vaccine story has further to run or believe the rally overshot, MRNA perpetual futures let you act on that view the moment the next headline hits.<\/span><\/p>\n<h2><span style=\"font-weight: 400; font-family: inter;\">Trade MRNA Perpetual Futures on BTSE<\/span><\/h2>\n<p><span style=\"font-weight: 400; font-family: inter; font-size: 14pt; color: #000000;\">Ready to trade Moderna&#8217;s next move 24\/7?<\/span><\/p>\n<p><span style=\"font-family: inter; font-size: 14pt;\"><span style=\"font-weight: 400;\">\ud83d\udc49 <\/span><a href=\"https:\/\/www.btse.com\/en\/futures\/MRNA-PERP\"><b>Trade MRNA-PERP on BTSE Futures now<\/b><\/a><\/span><\/p>\n<hr \/>\n<p><span style=\"font-size: 14pt; font-family: inter; color: #000000;\"><i><span style=\"font-weight: 400;\">This article is for informational purposes only and is not financial advice. Perpetual futures and leveraged products carry significant risk, including the risk of total loss and liquidation. Biotech stocks can experience extreme volatility around clinical and regulatory catalysts. Trade responsibly.<\/span><\/i><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Few stocks demonstrate why leveraged perpetual futures exist quite like Moderna just did. On August 19, 2026, MRNA shares rocketed 177% in a single session \u2014 the largest one-day gain in the company&#8217;s history \u2014 before giving back nearly 20% the very next day (BioSpace). That&#8217;s not a typo, and it&#8217;s exactly the kind of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17294,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[5],"tags":[892,894,893],"class_list":["post-17292","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-announcements","tag-mrna-perpetual-futures","tag-mrna-stock-futures","tag-trade-mrna-futures"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures &#8212; BTSE Blog<\/title>\n<meta name=\"description\" content=\"Moderna just posted the biggest single-day stock gain in its history on a landmark cancer vaccine win. Here&#039;s how to trade MRNA perpetual futures on BTSE, and why biotech volatility makes MRNA one of the sharpest tools available to perp traders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures\" \/>\n<meta property=\"og:description\" content=\"Moderna just posted the biggest single-day stock gain in its history on a landmark cancer vaccine win. Here&#039;s how to trade MRNA perpetual futures on BTSE, and why biotech volatility makes MRNA one of the sharpest tools available to perp traders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/\" \/>\n<meta property=\"og:site_name\" content=\"BTSE Blog\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T08:41:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.btse.com\/blog\/wp-content\/uploads\/2026\/08\/banner-mrna-perp.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"BTSE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BTSE_Official\" \/>\n<meta name=\"twitter:site\" content=\"@BTSE_Official\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BTSE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures &#8212; BTSE Blog","description":"Moderna just posted the biggest single-day stock gain in its history on a landmark cancer vaccine win. Here's how to trade MRNA perpetual futures on BTSE, and why biotech volatility makes MRNA one of the sharpest tools available to perp traders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/","og_locale":"en_US","og_type":"article","og_title":"How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures","og_description":"Moderna just posted the biggest single-day stock gain in its history on a landmark cancer vaccine win. Here's how to trade MRNA perpetual futures on BTSE, and why biotech volatility makes MRNA one of the sharpest tools available to perp traders.","og_url":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/","og_site_name":"BTSE Blog","article_published_time":"2026-08-27T08:41:20+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.btse.com\/blog\/wp-content\/uploads\/2026\/08\/banner-mrna-perp.png","type":"image\/png"}],"author":"BTSE","twitter_card":"summary_large_image","twitter_creator":"@BTSE_Official","twitter_site":"@BTSE_Official","twitter_misc":{"Written by":"BTSE","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#article","isPartOf":{"@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/"},"author":{"name":"BTSE","@id":"https:\/\/www.btse.com\/blog\/#\/schema\/person\/46ad80e1bffe6cf5d79938127822f2ca"},"headline":"How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures","datePublished":"2026-08-27T08:41:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/"},"wordCount":977,"commentCount":0,"publisher":{"@id":"https:\/\/www.btse.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.btse.com\/blog\/wp-content\/uploads\/2026\/08\/banner-mrna-perp.png?fit=1200%2C675&quality=75&ssl=1","keywords":["MRNA perpetual futures","mRNA stock futures","trade MRNA futures"],"articleSection":["Announcements"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/","url":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/","name":"How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures &#8212; BTSE Blog","isPartOf":{"@id":"https:\/\/www.btse.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#primaryimage"},"image":{"@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.btse.com\/blog\/wp-content\/uploads\/2026\/08\/banner-mrna-perp.png?fit=1200%2C675&quality=75&ssl=1","datePublished":"2026-08-27T08:41:20+00:00","description":"Moderna just posted the biggest single-day stock gain in its history on a landmark cancer vaccine win. Here's how to trade MRNA perpetual futures on BTSE, and why biotech volatility makes MRNA one of the sharpest tools available to perp traders.","breadcrumb":{"@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#primaryimage","url":"https:\/\/i0.wp.com\/www.btse.com\/blog\/wp-content\/uploads\/2026\/08\/banner-mrna-perp.png?fit=1200%2C675&quality=75&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.btse.com\/blog\/wp-content\/uploads\/2026\/08\/banner-mrna-perp.png?fit=1200%2C675&quality=75&ssl=1","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/www.btse.com\/blog\/trade-mrna-perpetual-futures\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.btse.com\/blog\/"},{"@type":"ListItem","position":2,"name":"How to Trade MRNA Perpetuals: A Guide to mRNA Stock Futures"}]},{"@type":"WebSite","@id":"https:\/\/www.btse.com\/blog\/#website","url":"https:\/\/www.btse.com\/blog\/","name":"BTSE Blog","description":"Navigating the Crypto Frontier - Insights, Analysis, and Strategies","publisher":{"@id":"https:\/\/www.btse.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.btse.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.btse.com\/blog\/#organization","name":"BTSE","url":"https:\/\/www.btse.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.btse.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.btse.com\/blog\/wp-content\/uploads\/2023\/03\/btse-logo.png","contentUrl":"https:\/\/www.btse.com\/blog\/wp-content\/uploads\/2023\/03\/btse-logo.png","width":1007,"height":306,"caption":"BTSE"},"image":{"@id":"https:\/\/www.btse.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/BTSE_Official","https:\/\/discord.com\/invite\/btse","https:\/\/www.linkedin.com\/company\/btsecom\/","https:\/\/t.me\/btsecom"]},{"@type":"Person","@id":"https:\/\/www.btse.com\/blog\/#\/schema\/person\/46ad80e1bffe6cf5d79938127822f2ca","name":"BTSE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/dc01110861deb9c4a6b15c6c841e4457320749d7c005164340fbf8d4eacefc5d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dc01110861deb9c4a6b15c6c841e4457320749d7c005164340fbf8d4eacefc5d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc01110861deb9c4a6b15c6c841e4457320749d7c005164340fbf8d4eacefc5d?s=96&d=mm&r=g","caption":"BTSE"},"sameAs":["https:\/\/www.btse.com\/blog"],"url":"https:\/\/www.btse.com\/blog\/author\/btseadmin\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.btse.com\/blog\/wp-content\/uploads\/2026\/08\/banner-mrna-perp.png?fit=1200%2C675&quality=75&ssl=1","_links":{"self":[{"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/posts\/17292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/comments?post=17292"}],"version-history":[{"count":1,"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/posts\/17292\/revisions"}],"predecessor-version":[{"id":17296,"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/posts\/17292\/revisions\/17296"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/media\/17294"}],"wp:attachment":[{"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/media?parent=17292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/categories?post=17292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.btse.com\/blog\/wp-json\/wp\/v2\/tags?post=17292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}